A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients.
暂无分享,去创建一个
A. Uitterlinden | E. Berns | H. Pols | I. Braakman | A. Themmen | M. Verhoef-Post | D. Piersma | A. Uitterlinden
[1] A. Hofman,et al. A direct approach to the estimation of the origin of oestrogens and androgens in elderly men by comparison with hormone levels in postmenopausal women. , 2005, European journal of endocrinology.
[2] J. Martens,et al. Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398. , 2004, Molecular endocrinology.
[3] E. Simpson. Sources of estrogen and their importance , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[4] A. Hirvonen,et al. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. , 2003, Mutation research.
[5] V. Lingappa,et al. Signal Sequences Initiate the Pathway of Maturation in the Endoplasmic Reticulum Lumen* , 2003, Journal of Biological Chemistry.
[6] E. Berns,et al. Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset. , 2003, The Journal of clinical endocrinology and metabolism.
[7] M. Heineman,et al. The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer. , 2002, Maturitas.
[8] F. Abdul-Karim,et al. Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. , 2002, Endocrinology.
[9] H. Brunner,et al. Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene , 2002, Clinical endocrinology.
[10] P. Goss,et al. Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.
[11] I. Huhtaniemi,et al. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. , 2000, Endocrine reviews.
[12] J. Yager,et al. Tissue-specific synthesis and oxidative metabolism of estrogens. , 2000, Journal of the National Cancer Institute. Monographs.
[13] A. Dehejia,et al. Genomic Distribution and Gonadal mRNA Expression of Two Human Luteinizing Hormone Receptor Exon 1 Sequences in Random Populations , 1999, Human Heredity.
[14] F. Cetani,et al. Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors. , 1998, The Journal of clinical endocrinology and metabolism.
[15] J. Wilson,et al. Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. , 1998, Molecular endocrinology.
[16] B. Martoglio,et al. Signal sequences: more than just greasy peptides. , 1998, Trends in cell biology.
[17] J. Martens,et al. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. , 1998, Molecular endocrinology.
[18] H. Brunner,et al. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. , 1995, The Journal of clinical endocrinology and metabolism.
[19] M. Heineman,et al. Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy. , 1995, The Journal of clinical endocrinology and metabolism.
[20] E. Milgrom,et al. Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5′ non-coding regions , 1995, Molecular and Cellular Endocrinology.
[21] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[22] J. Foekens,et al. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. , 1992, European journal of cancer.
[23] A. Hofman,et al. Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.
[24] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[25] J. Martens,et al. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency. , 2002, The Journal of clinical endocrinology and metabolism.
[26] H. Pols,et al. The Prevalence of Low Bone Mineral Density in Dutch Perimenopausal Women: The Eindhoven Perimenopausal Osteoporosis Study , 1998, Osteoporosis International.
[27] C. Stratowa,et al. Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. , 1993, Journal of receptor research.
[28] S. Kornfeld,et al. Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.